modafinil — CareFirst (Caremark)

Initial criteria

• Authorization may be granted when the requested drug is being prescribed for multiple sclerosis-related fatigue.

Reauthorization criteria

• The patient has achieved or maintained a positive response to treatment from baseline.

Approval duration

12 months